Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT03565367 Completed - Clinical trials for Malignant Central Nervous System Neoplasm

Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Detecting Lactate and Bicarbonate in Participants With Central Nervous System Tumors

Start date: November 6, 2018
Phase: Phase 1
Study type: Interventional

This early phase I trial studies how well hyperpolarized carbon C 13 pyruvate magnetic resonance imaging works in detecting lactate and bicarbonate in participants with central nervous system tumors. Hyperpolarized carbon C 13 pyruvate magnetic resonance imaging may be used to measure the metabolic state of malignant brain tumors.

NCT ID: NCT03565289 Completed - Clinical trials for Indication for Prostate Biopsy Due to Suspected Prostate Cancer

PRospective Prostate biOmarker Study

PROPOSe
Start date: August 14, 2018
Phase:
Study type: Observational

• Correlation of a glycoprotein panel with prostate biopsy outcome and PCa aggressiveness

NCT ID: NCT03565263 Completed - Quality of Life Clinical Trials

Functional Gastrointestinal Disorders in Pediatric IBD

TFI-MICI
Start date: April 3, 2018
Phase:
Study type: Observational

Background: Persistent gastrointestinal symptoms have been described in patients who are considered in remission of their inflammatory bowel disease (IBD). These symptoms, attributed to Functional gastrointestinal disorders (FGID) in IBD, may have a significant impact of quality of life, and may be associated with fatigue, anxiety and depression. There is very little data regarding pediatric specificities of these FGID. Aims: The aim of the study is to evaluate the prevalence of FGID in pediatric patients with IBD in remission. Secondary aims are to investigate a possible association of FGID with fatigue, anxiety, depression and impacted quality of life in the patients, as well as anxiety and depression in the parents. Methods: This will be an observational, case-control study. All patients between 9 and 18 years old , with IBD in remission will be invited to participate. Questionnaires will be web-based and will evaluate: presence of FGID (Fr-qPGS), fatigue (FACIT-F), anxiety (SCARED-R), depression (CDI), quality of life (IMPACT-III). Parents will be invited to fill in web-based questionnaires on their symptoms of anxiety (STAI/Y-A and STAI/Y-B) and depression (BDI). Clinical parameters will be retrieved retrospectively from the chart. Level of remission will be confirmed by most recent blood tests and fecal calprotectin. Patients with FGID will be compared to patients without FGID in terms of clinical characteristics, disease phenotype and associated psychological comorbidities.

NCT ID: NCT03565211 Completed - Clinical trials for Progesterone Supplementation in Women Undergoing ART

Clinical Safety Study of the Progesterone Vaginal Ring in Women Undergoing Assisted Reproductive Technology Procedures

SARA
Start date: July 26, 2018
Phase: Phase 3
Study type: Interventional

The purpose of the study is to assess the safety of Progesterone Vaginal Ring (PVR) in women undergoing fresh embryo transfer (ART).

NCT ID: NCT03564522 Completed - Clinical trials for Pulmonary Hypertension

Image-based Multi-scale Modeling Framework of the Cardiopulmonary System: Longitudinal Calibration and Assessment of Therapies in Pediatric Pulmonary Hypertension

Start date: April 1, 2017
Phase:
Study type: Observational

This study looks to develop a multi-scale computational model of Pulmonary Hypertension, this clinical model will be calibrated using longitudinal, retrospectively and prospectively acquired human clinical data.

NCT ID: NCT03564405 Completed - Clinical trials for Hepatocellular Carcinoma Non-resectable

Pilot Clinical Trial to Evaluate the UNI-DEB for Unresectable Hepatocellular Carcinoma

Start date: December 5, 2016
Phase: N/A
Study type: Interventional

Pilot Clinical Trial to Evaluate the Efficacy and Safety of UNI-DEB for Unresectable Hepatocellular Carcinoma

NCT ID: NCT03563651 Completed - Clinical trials for Stage IV Colorectal Cancer AJCC v8

Collection of Blood, Urine, and Stool to Monitor MetastaticColorectal Cancers

Start date: February 6, 2014
Phase:
Study type: Observational

This trial studies the monitoring of therapy and progression by collecting blood, urine, and stool from participants with colorectal cancer that has spread to other places in the body or cannot be removed by surgery. Studying samples of blood, urine, and stool from participants with colorectal cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer.

NCT ID: NCT03563612 Completed - Clinical trials for Continuous Positive Airway Pressure

Differential Lung Ventilation vs. CPAP

Start date: April 1, 2017
Phase: N/A
Study type: Interventional

In this study we compared the efficacy of continuous positive airway pressure (CPAP) to differential lung ventilation, in terms of patient's oxygenation, during video assisted thoracoscopic lung resection.

NCT ID: NCT03563599 Completed - Clinical trials for Treatment-naïve, Sputum Smear-positive Patients With Drug-sensitive Pulmonary TB

A Phase 2 Study to Evaluate Early Bactericidal Activity, Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of Telacebec (Q203)

Start date: July 23, 2018
Phase: Phase 2
Study type: Interventional

This is a Phase IIa, open-label, randomized study in treatment-naïve, sputum smear-positive patients with drug-sensitive pulmonary TB to assess the early bactericidal activity of telacebec (Q203).

NCT ID: NCT03563547 Completed - Clinical trials for Heterozygous Familial Hypercholesterolemia

Effects of Soy Protein on Cholesterol Levels in Children Affected With Familial Hypercholesterolemia

SOYFIT
Start date: September 3, 2009
Phase: N/A
Study type: Interventional

Familial hypercholesterolemia (FH) is an inheritable, autosomal dominant disorder leading to pathologically increased levels of low-density-lipoprotein cholesterol (LDL-C). Dietary treatment remains an important tool in the management of affected children even after the decision for the initiation of pharmacotherapy is made. However, little evidence is available on the beneficial effects of diets low in saturated fat and cholesterol and diets enriched with soy in children affected with FH. Based on these previous findings we hypothesize that the LDL-C lowering effect of a fat-modified diet could be further increased by the addition of soy-protein in children affected with HeFH.